Simpler Grants.gov #FOR-FD-25-006

FDA Grant for Research Advancing Medical Product Development for ALS and Rare Neurodegenerative Diseases

The Food and Drug Administration (FDA) is seeking applications for a grant program supporting research studies that advance medical product development for ALS and other rare neurodegenerative diseases. - Government Buyer: - Food and Drug Administration (FDA) - Eligible Applicants: - State, city, county, and tribal governments - Educational institutions - Nonprofits - Small businesses - Products/Services Requested: - Research studies focused on interventions to prevent, diagnose, mitigate, treat, or cure ALS and rare neurodegenerative diseases in adults and children - No specific products, part numbers, or quantities are listed - Unique/Notable Requirements: - Grant aims to address critical knowledge gaps and inform current or future medical product development - No cost sharing or matching required - Funding instrument is a grant, not a contract - OEMs and Vendors: - No specific OEMs or vendors are mentioned in this opportunity

Description

This funding opportunity supports studies that advance medical product development for interventions to prevent, diagnose, mitigate, treat, or cure ALS and other rare neurodegenerative diseases in adults and children. The FDA aims to address critical knowledge gaps and impact product development through these studies. The opportunity is targeted at a wide range of eligible applicants including government entities, educational institutions, nonprofits, and small businesses.

View original listing